Membership of Professional Bodies
- Executive Committee, European Atherosclerosis Society, 2017
- Fellow, American College of Cardiology
- Fellow, American Heart Association
- Member, British Cardiovascular Society
- Member, European Atherosclerosis Society
- Fellow, European Society of Cardiology
- Member, Independent Doctors Federation
- Member, Royal Society of Medicine
Links with Other Academic Bodies
- Amsterdam Medical Centre (AMC)
- C5 Clinical Research, Cleveland Clinic
- European Atherosclerosis Society (EAS)
- Harvard Clinical Research Institute (HCRI)
- Imperial Clinical Trials Unit (ICTU)
- South Australia Health Medical Research Institute (SAHMRI)
- University of Leicester
- University of Manchester
Industrial Connections
- AbbVie, Events Adjudication Committee Member of the SONAR clinical trial
- AstraZeneca, National Lead Investigator of the Savor TIMI 53 clinical trial and the Declare TIMI 58 clinical trial, National Lead Investigator and Steering Committee Member of the THEMIS Phase 3 RCT clinical trial, National Lead Investigator and Executive Committee Member of the STRENGTH clinical trial
- Cerenis, Executive Committee Member of the CARAT clinical trial
- Eisai, Steering Committee Member of the CAMELLIA TIMI 61 clinical trial
- Esperion, Executive Committee Member of the CLEAR CVOT clinical trial and the HARMONY Esperion Lipid Lowering Trials clinical trial
- European Atherosclerosis Society (EAS), PI of the EAS Familial Hypercholesterolaemia (FH) Collaboration (sponsored with MSD, Amgen, and Sanofi)
- Kowa, Steering Committee Member of the PROMINENT clinical trial
- Lilly, Executive Committee Member of the ACCENTUATE clinical trial and the Lilly Phase 3 Lipid lowering programme of a novel PCSK9 Mab, Chair of Statin Intolerance Study
- Medicines Company, PI and Co-chair of the Executive Committee for the ORION 1 clinical trial
- Pfizer, PI to a grant to establish a risk prediction tool for additional lipid lowering therapies and to the global grant for dyslipidemia to establish a global collaborative registry of Familial Hypercholesterolaemia (FH)
- Resverlogix, Chair of International Executive Committee of the BETONMACE clinical trial
- Sanofi, PI of the Investigator Initiated TOGETHER study
- Sanofi Regeneron, National Lead Investigator of the Odyssey Outcomes clinical trial, Executive Committee Member of the Odyssey Diabetes 1 clinical trial and the Odyssey Diabetes 2 clinical trial
Editorial Boards
- Archives of Medicine, Associate Editor
- European Heart Journal, International Associate Editor
- British Journal of Cardiology
- Future Forum - Lipids, International Board Member
- Circulation, Editorial Board
- European Atherosclerosis Society
- International Journal of Clinical Practice